AMERICAN FINANCIAL GROUP, INC. (AFG): what the price assumes
In the published model solve dated 2026-Q2, anchored at $142.72, AMERICAN FINANCIAL GROUP, INC. (AFG) is priced for 15.8% return on equity. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.
Generated: 2026-09-07 · Exported: 2026-09-09 · Source: https://boothcheck.com/report/AFG
Headline
| Field | Value |
|---|---|
| Ticker | AFG |
| Company | AMERICAN FINANCIAL GROUP, INC. |
| Sector / Industry | Financial Services |
| Current price | $142.72/sh |
What The Price Assumes (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | financials |
| Return on equity needed | 15.8% |
| Return on equity now | 17.5% |
| ROE gap | -1.7pp |
| Price-to-book | 2.45x |
Solve inputs: computed at a 8.8% cost of equity with 4% terminal growth over a 10-year stage, on common book equity (FY2026).
How unusual the bet is: within-range
| Reference | Value |
|---|---|
| vs own history | +0.53σ |
| cohort percentile (of 78 peers) | 72 |
| sustained it ~10 years at this level | 57% |
| implied end-window share | 0% |
Valuation X-Ray
The price is supported by asset-based and earnings-power value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.15x | 3 | expensive |
| Earnings | 1.15x | 1 | expensive |
| Relative | — | 0 | — |
| Growth | — | 0 | — |
Families that justify the price: Asset, Earnings
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.2%); the inversion above states its own rate.
Per-Model Detail (n=4)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | — | — | no | — |
| Bank Fair Value (P/TBV) | — | $180.82 | 0.79x | yes | TBVPS $52.04 × 3.47x (ROE (TTM) 19.8% / CoE 9.3%, g=5.0% (sustainable: 65% retention × ROE, 5% cap; not the terminal-growth assumption)) |
| Relative Valuation | Relative | — | — | no | P/E 11x (static sector reference · 2026-04), scenarios: 9.3x / 11.0x / 12.7x (bear / base = reference held flat / bull), EV/EBITDA 10x |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | — | — | no | — |
| Simple Excess Return | Asset | $124.25 | 1.15x | yes | BV/sh $58.14, ROE (TTM) 19.8%, ke 9.3% |
| Two-Stage Excess Return | Asset | $179.70 | 0.79x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | — | — | no | Rev $8.3B, growth -0% (input: historical growth; tapered), Terminal P/S: 1.2x / 1.4x / 1.7x (bear / base = today's held flat / bull, cap 8x) |
| Peter Lynch Fair Value | Relative | — | — | no | EPS $11.45, growth 27% (input: historical EPS growth), PEG=0.47 (Undervalued) |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | — | — | no | — |
| Graham Number | Asset | $122.39 | 1.17x | yes | √(22.5 × EPS $11.45 × BVPS $58.14) — Graham's conservative floor |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | — | — | no | — |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | EPS $11.45 × (8.5 + 2×15.0%) × (4.4 / 5.3%) |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | — | — | no | — |
| PEG Fair Value | Relative | — | — | no | EPS $11.45 × (PEG 1.5 × growth 25.0% (input: historical EPS growth)) → PE 37.5x |
| Earnings Yield | Earnings | $123.78 | 1.15x | yes | EPS $11.45 / required return 9.3% (Rf 4.3% + ERP 5.0%) |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Share count CAGR (buyback) | -0.7% |
Deposit/float-funded balance sheet: debt is funding, not corporate leverage, and GAAP operating cash flow follows loan flows. Net-debt, interest-coverage, and cash-burn lenses do not apply. The solvency frame for a financial is regulatory capital and payout capacity (CET1, stress buffer, dividends plus buybacks against earnings).
Bullet Takeaways
- A specialty underwriter is judged on what it earns on the capital it holds, and American Financial has been earning about 17.5% on its equity while the price asks it to sustain roughly 16.6%.
- The pressure point is the investment side rather than the underwriting side: the annualized return earned on alternative investments was 2.5% in 2025 compared to 6.1% in 2024, and property and casualty net investment income fell 8% to $725 million.
- Second quarter results arrive after the close on August 4, 2026, with crop premiums and renewal pricing the two lines that decide whether the underwriting improvement of early 2026 holds.
Bull Case
Valuing an insurer is a different exercise from valuing almost anything else. There is no product margin to model and no unit economics to scale. An insurance company takes in premiums today against claims it will pay years from now, invests the money while it waits, and its entire economic result reduces to two questions: did it price the risk correctly, and what did it earn on the money it held in the meantime. That is why insurers are read on what they earn on their capital rather than on a multiple of revenue. For American Financial the answer to that question is about 17.5% on equity, which puts it near the top of what a property and casualty underwriter can produce without taking exotic risk.
The reason it gets there is a business model built around walking away. American Financial writes specialty lines: crop, workers' compensation, transportation, surety and fidelity, financial institutions, excess and surplus. The 10-K is unusually blunt about how it manages them, describing them as opportunistic with premium volume that will vary based on prevailing market conditions and stating that AFG will withdraw from markets that do not meet its profit objectives. That is not boilerplate in this case, because the numbers show it happening. Premium growth in the transportation businesses was held back by elevated pricing competition and the non-renewal of certain under-performing accounts, while average renewal rates across the specialty casualty group rose about 8% in 2025. The company let volume go where price was bad and pushed rate where it was good. Revenue that stays roughly flat while returns stay high is what that discipline looks like from outside.
Scale is not the moat here, and that is the point worth sitting with. Against a cohort where Travelers writes $48.9B of revenue, Hartford $28.8B, AIG $26.6B and W. R. Berkley $14.9B, American Financial's roughly $8.2B is small. In commodity insurance lines that would be a disadvantage, because the low-cost writer with the biggest reinsurance leverage wins. In specialty lines it is closer to an advantage: the accounts are small enough that a large carrier cannot underwrite them profitably at scale, and the pricing is set by underwriting judgment rather than by market share. Travelers itself describes an approach that emphasizes product returns and profitable growth over time rather than premium volume or market share, which is the same philosophy stated by a company forty times the size that has to apply it across a far broader book.
Reserving has been the quiet confirmation. Adverse prior year development ran to just $5 million in 2025, $6 million in 2024 and $2 million in 2023, and it came from runoff business outside the specialty group that the company no longer writes. On the active book the development has gone the other way, with favorable development reflecting lower than anticipated claim severity in the workers' compensation businesses. Reserve development is the closest thing insurance has to a lie detector, because it reveals after the fact whether management's original loss estimates were honest. Three years of small adverse development confined to a discontinued book is a good answer.
Capital allocation follows the same unglamorous pattern. About 83.7% of the last fiscal year's earnings went back to shareholders as dividends and buybacks, with the share count drifting down roughly 0.6% a year over four years. Management has raised its outlook on 25 separate occasions against a single cut since 2006, a cadence that suggests the company knows its own loss picks before the market does.
Bear Case
The variable with the most leverage over this business is one the company does not control and cannot underwrite around. American Financial is one of the larger writers in the federal crop insurance program, and the 10-K states plainly that as a participant in the federal crop insurance program, AFG could also be impacted by regulatory, executive and legislative actions. The program's terms, subsidy structure and loss-sharing arrangements are set in Washington rather than by the underwriter. Layered on top of that is the commodity cycle, which moves the premium base directly: the company attributes softer growth in part to the impact of lower year-over-year commodity pricing on winter wheat premiums. Grain prices set how much insurance a farmer buys. Neither the crop program nor grain prices respond to good underwriting.
The second external variable showed up in the results already. American Financial holds a portfolio of alternative investments alongside its bonds, and the annualized return earned on alternative investments was 2.5% in 2025 compared to 6.1% in 2024. Property and casualty net investment income fell to $725 million in 2025 from $784 million, a decrease of $59 million (8%). That is what pulled full year 2025 net earnings down to $842 million ($10.08 per share, diluted) from $887 million ($10.57 per share, diluted) in 2024, in a year when underwriting itself improved. An insurer's return on equity is the sum of an underwriting result and an investment result, and roughly half of that sum is currently hostage to private-market marks and interest rates.
That matters more than usual because of how little room the price leaves. At about 2.6 times book value, the price requires the company to keep returning something close to 16.6% on equity. The cushion between the return the business has actually been producing and the return the price needs is under a percentage point, and of firms earning at this level historically, only around 56% held it for as long as a decade. If returns settle into the low teens instead, the multiple has to come down, and there is no growth to catch the fall: the top line has been roughly flat to slightly negative over the trailing year, so the entire equity story rests on the return staying where it is.
Competition is the mechanism most likely to push it. The 10-K's own risk language is direct: intense competition could adversely affect AFG's results of operations, in a market it describes as cycling through periods characterized by increased competition, resulting in less restrictive underwriting standards and relatively low premium rates. That cycle is visible in the peer group right now. Travelers reported a combined ratio of 89.9% in 2025, 2.6 points lower than the combined ratio of 92.5% in 2024, with net favorable prior year development adding 1.1 points of that benefit. When the largest carriers are earning underwriting profits this comfortably, capital comes into the market and rates soften, and specialty lines soften last but they do soften. Selective grew revenue 8.6% and W. R. Berkley 6.6% over the trailing year while American Financial's book shrank slightly.
None of this is a solvency argument, and it would be dishonest to dress it up as one. The holding company's borrowing is modest and recently termed out, with $350 million in 5.00% Senior Notes due in September 2035 issued in September 2025, and an insurer funded by premium float is not read on corporate leverage in the first place. The bear case is narrower. It is that a stock priced at more than two and a half times book with almost no growth is a pure bet on a high return persisting, and two of the three inputs to that return are set by grain markets, credit markets and Congress.
Valuation
Start with what 2.6 times book value actually means. For an operating company a book multiple is a rough shorthand; for an insurer it is close to a direct statement about return. Pay 2.6 times the equity and you are assuming the company keeps earning something like 16.6% on that equity, long enough for the compounding to justify the premium over the accounting value of the assets. American Financial has recently been earning about 17.5%. That makes this one of the less demanding setups in the market: the price is asking for slightly less than the business has actually been producing.
The assumption is more sensitive to interest rates than to underwriting. The calculation rests on a required return of roughly 8.9%, and each percentage point added to that required return raises the return on equity the price needs by about 2.6 points. Move the required return up by half a point and the comfortable gap between demonstrated and required disappears. This is the real fragility in the price, and it sits in the bond market rather than in the loss ratios.
The methods used to triangulate the value all land within a fairly narrow band, which is itself the finding. The approaches that value the company on the earnings it produces now put it above today's price, by roughly a tenth. Peer multiples land roughly an eighth under the price and the asset-value approaches roughly a quarter under it, while the forward-growth approaches land closest of all, a shade below. No single family is screaming. Compare that with the usual shape of a richly priced stock, where only the growth-dependent methods can reach the price at all and everything static sits far beneath it. Here the static methods are in the conversation. What the market is paying for is a durable high return on a stable book, not a story about the future.
Against the cohort, the price-to-book sits in the upper half of the peer group, which is where a company earning near 17.5% on equity should sit. Whether it deserves to sit at the top of that half is the harder question, and the peer numbers frame it: Selective grew revenue 8.6% over the trailing year and W. R. Berkley 6.6%, while American Financial's revenue base of roughly $8.2B was slightly lower than a year earlier. The premium here is being paid for return quality, not for expansion.
Which leaves the payout as the mechanism that actually delivers the return to the holder. About 83.7% of the last fiscal year's earnings went out as dividends and buybacks, with the share count down roughly 0.6% a year over four years. That is a company that has concluded it cannot deploy most of its earnings into new underwriting at attractive rates and is handing them back instead. For an insurer, that decision is informative in both directions. It confirms the discipline, and it tells the buyer at this price exactly what they are underwriting: a distribution stream from a high-return book, with almost none of the return coming from the book getting bigger.
Catalysts
The next scheduled information event is close. American Financial expects to release second quarter 2026 results after the close on August 4, 2026, with the management call the following morning. The line to watch in that release is the specialty property and casualty combined ratio, which came in at 90.3% for the first quarter of 2026, an improvement of 3.7 points from 94.0% in the first quarter of 2025. A combined ratio measures claims and expenses against premiums earned, so a reading in the low nineties means the company kept roughly a dime of every premium dollar before counting anything it earned on investments. Whether that improvement carried into the second quarter is the practical question, and the crop book, which concentrates its result in the second half of the growing season, will not be fully settled either way.
Capital return has continued on its established rhythm. The board declared a regular quarterly dividend of $0.88 per share, payable July 24, 2026 to holders of record on July 15, 2026, and earlier in the year declared a special cash dividend of $1.50 per share, roughly $125 million in aggregate. The special dividend is the more informative of the two. American Financial uses it as a release valve for capital it has decided it cannot deploy into underwriting at target returns, so its size functions as a running commentary on how attractive management finds current market pricing.
The investment portfolio is the third thing worth tracking, for the reason the last full year made obvious. Returns on the alternative investments book fell sharply in 2025 and took property and casualty investment income down 8% with them, in a year when underwriting results improved. Those marks arrive with a lag and move the reported return on equity more than a point of combined ratio does.
Peer Cohorts (Per Segment, With Filing Citations)
Core business (reported)
- CNA (CNA FINANCIAL CORP)
- FY2025 10-K: …adverse effect on our business, results of operations and financial condition. 8 Table of Contents Strategic Risks We face intense competition in our industry; we may be adversely affected by the cyclical nature of the property and casualty business and by the evolving landscape of our distribution network. All…
- FY2025 10-K: As such, only Insurance and Reinsurance receivables, Insurance reserves, Deferred acquisition costs, Goodwill and Deferred non-insurance warranty acquisition expense and revenue are readily identifiable for individual segments. Distinct investment portfolios are not maintained for every individual segment;…
- THG (HANOVER INSURANCE GROUP, INC.)
- FY2025 10-K: …at acceptable margins, and we continue to seek rate increases across many lines of business, as appropriate. Personal Lines Personal Lines focuses on working with high quality, value-oriented agencies that deliver consultative selling to customers and stress the importance of total account solutions, which is the…
- FY2025 10-K: …ratings and effective claims handling, among other things. Our competitors include national, international, regional and local companies that sell insurance through various distribution channels, including independent agencies, captive agency forces, brokers, and direct to consumers, through the internet or…
- EG (EVEREST GROUP, LTD.)
- FY2025 10-K: …be $347 billion in 2024 according to data compiled by S&P. In addition to existing competitors, the entry of alternative capital market products and new company formations, such as Insurtech companies, provide additional sources of reinsurance and insurance capacity, which could reduce our market share and adversely…
- FY2025 10-K: …include careful risk selection, appropriate pricing through strict underwriting discipline and adjustments to the Company's business mix as market conditions change. We focus on 3 Table of Contents (re)insuring companies that effectively manage their own underwriting cycle through proper analysis and appropriate…
- AIG (American International Group, Inc.)
- FY2025 10-K: …reserve discount and the portion of favorable or unfavorable prior year reserve development for which we have ceded the risk under retroactive reinsurance agreements and related changes in amortization of the deferred gain. Premiums Years Ended December 31, 2025 and 2024 Comparison Net premiums written increased by…
- FY2025 10-K: …Commercial segment consists of insurance businesses and operations in Middle East and Africa (EMEA region), the United Kingdom, Japan, Europe, Asia Pacific, Latin America and Caribbean, and China. The International Commercial segment also includes the results of Talbot Holdings Ltd. (Talbot) as well as AIG's Global…
- WRB (W. R. BERKLEY CORP)
- FY2025 10-K: …lines of business continue to decrease. We face significant competitive pressures in our businesses, which can pressure premium rates in certain areas and could harm our ability to maintain or increase our profitability and premium volume in some parts of our business. We compete with a large number of other…
- FY2025 10-K: …substantial infusions of capital or access to third-party capital, provide increasing competition, which may adversely impact our business and profitability. Further, an expanded supply of capital may lower costs for insurers and, as a consequence, those insurers may be able to price their products more…
- TRV (Travelers Companies, Inc.)
- FY2025 10-K: …well as to our competitors. Pension and hedge funds and other entities with substantial available capital, more flexible legal structures and/or potentially lower return objectives have increasingly sought to participate in the property and casualty insurance and reinsurance businesses. Well-capitalized new entrants…
- FY2025 10-K: …that emphasizes product returns and profitable growth over time rather than premium volume or market share. The Company's insurance subsidiaries are subject to state laws and regulations regarding rate and policy form approvals. The applicable state laws and regulations establish standards in certain lines of…
- SIGI (SELECTIVE INSURANCE GROUP, INC)
- FY2025 10-K: …Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations." of this Form 10-K. 6 Table of Contents Insurance Operations Overview Our insurance operations generate revenue by selling insurance policies and services in exchange for insurance premiums. Nearly all our sales come from…
- FY2025 10-K: …of the first layer through a 20% co-participation. The 2025 treaty year deposit premium decreased, primarily due to increased retention and co-participation, partially offset by higher projected subject-earned premium due to growth of our book of business. To complement our key reinsurance programs and provide…
- HIG (The Hartford Insurance Group, Inc.)
- FY2025 10-K: …an increasingly prominent role in influencing customer decisions that also influence selection of the employee benefits insurance provider. Carriers across the industry are increasing automated interfaces and digital workflows to meet distributor and employer expectations and to improve service and claim experiences.…
- FY2025 10-K: …(a) premiums earned for insurance coverage provided to insureds; (b) management fees on mutual fund and ETF assets; (c) net investment income; (d) fees earned for services provided 42 Table of Contents Index to MD&A Part II - Item 7. Management's Discussion and Analysis of Financial Condition and Results of…
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
company conference call announcement, July 14, 2026 · Q1 2026 earnings release, April 2026 · company dividend declaration, July 1, 2026 · company special dividend declaration, February 2026